1-(4-Bromobenzenesulfonyl)-5-(trifluoromethyl)-2,3-dihydro-1H-1,4-diazepine

Catalog No. :
ACPOSU317
CAS No. :
478259-66-4
Molecular Formula :
C12H10BrF3N2O2S
Molecular Weight :
383.19

IUPAC Name:1-((4-bromophenyl)sulfonyl)-5-(trifluoromethyl)-2,3-dihydro-1H-1,4-diazepine

1-(4-Bromobenzenesulfonyl)-5-(trifluoromethyl)-2,3-dihydro-1H-1,4-diazepine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$506.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Bromobenzenesulfonyl)-5-(trifluoromethyl)-2,3-dihydro-1H-1,4-diazepine
IUPAC Name1-((4-bromophenyl)sulfonyl)-5-(trifluoromethyl)-2,3-dihydro-1H-1,4-diazepine
MDL No.MFCD02571395
Molecular FormulaC12H10BrF3N2O2S
Molecular Weight383.19
SMILESFC(C1=NCCN(S(=O)(C2=CC=C(Br)C=C2)=O)C=C1)(F)F
InChI KeySRACTDDFRLXRBS-UHFFFAOYSA-N
Synonym1-[(4-BROMOPHENYL)SULFONYL]-5-(TRIFLUOROMETHYL)-2,3-DIHYDRO-1H-1,4-DIAZEPINE;1H-1,4-Diazepine, 1-[(4-bromophenyl)sulfonyl]-2,3-dihydro-5-(trifluoromethyl)-
CAS No.478259-66-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPOSU317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPOSU317 route product structure diagram
    ACPOSU317478259-66-4
Inquiry

2. ACPOSU317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDCXW026 route compound structure diagram
    ACDCXW026138-36-3 In Stock
  4. Then
  5. ACPOSU317 route product structure diagram
    ACPOSU317478259-66-4
Inquiry

Comments (0)